You are here: Industry Insights > Market News > Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

firstwordpharmaJuly 12, 2021

Tag: Sputnik V , COVID-19 , mRNA vaccine , SARS-CoV-2

Favorites

Viral vector and mRNA vaccines, including Russia's Sputnik V, provide enough protection against the new Delta strain of the coronavirus, albeit to a lesser extent, reported The Times of India.

The observation was made by Sergey Netesov, head of the Novosibirsk State University's Laboratory and member of the Russian Academy of Sciences.

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

They offered 95% protection against the initial strain and now they give 90% protection against the Delta variant, Netesov said.

Sputnik V uses two different engineered adenoviruses (rAd26 and rAd5 for the first and second doses, respectively) to deliver the genetic code for the spike protein of SARS-CoV-2.

Previous:Unvaccinated Belgian woman contracted two COVID variants simultaneously

Next:Israeli co Bonus BioGroup reports Covid-19 treatment success

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>